Combination of Lenalidomide and Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL).
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Lenalidomide (Primary) ; Ofatumumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 01 Feb 2018 Status changed from active, no longer recruiting to completed.
- 30 Jan 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2021.
- 30 Jan 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Jan 2020.